biologics
| 3 min read
As therapies grow more complex, inactive ingredient innovation is needed to improve drug impact and access.
| 2 min read
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model.
| 2 min read
New data suggests icotrokinra could challenge injectables with once-daily targeted peptide.
| 2 min read
Bio-Rad has expanded its portfolio of recombinant monoclonal anti-idiotypic antibodies and SpyCatcher reagents, enhancing support for bioanalytical assay development and antibody drug research.
| 5 min read
Advances in microfluidics are enabling more powerful, high throughput applications in single cell and therapeutic discovery.
| 5 min read
Biologics like monoclonal antibodies and mRNA vaccines are complex drugs. Yongchao Su uses biophysical tools and innovative strategies to understand them better.
| 8 min read
New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.
| 1 min read
The discovery of insulin and its role in diabetes began with extracting canine pancreatic secretions and culminated in the first artificial pancreas in 2016.
| 10+ min read
Researchers developed ingestible capsules that inject drugs into the stomach and small intestine, providing a novel oral delivery method for biologics.
| 4 min read
People with COVID-19 sometimes lose their sense of smell. But a clinical researcher has a possible solution: the patient’s own blood.
